Literature DB >> 3458941

Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences.

L Bernstein, R H Depue, R K Ross, H L Judd, M C Pike, B E Henderson.   

Abstract

Serum samples drawn from 34 women in the early part of both their first and their second pregnancies were assayed for estradiol (E2), percentage of free E2, and sex hormone-binding globulin-binding capacity (SHBG-bc). Subjects were participants in the Collaborative Perinatal Study conducted by the National Institute of Neurological and Communicative Disorders and Stroke (Bethesda, MD) to evaluate factors related to adverse pregnancy outcome. All pregnancies were full term, and no offspring had a congenital malformation. After adjustment for week of pregnancy, the percentage of free E2 was 9% higher (two-sided P = .007) and the amount of free E2 was 17% higher (two-sided P = .03) in first-pregnancy sera. Total E2 was also 7% higher in first-pregnancy sera after adjustment for week of pregnancy; SHBG-bc was 7% lower after adjustment for week of pregnancy and 9% lower after simultaneous adjustment for week of pregnancy and weight at the start of pregnancy; but these differences were not statistically significant. These findings confirm our previously published hypothesis that the early part of a woman's first pregnancy differs endocrinologically from her second and may provide further insight into pregnancy-related risk factors for testis cancer and cryptorchidism and into the protection afforded by first full-term pregnancy against breast cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458941

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  48 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  Does nausea and vomiting of pregnancy play a role in the association found between maternal caffeine intake and fetal growth restriction?

Authors:  S M Boylan; D C Greenwood; N Alwan; M S Cooke; V A Dolby; A W M Hay; S F L Kirk; J C Konje; N Potdar; S Shires; N A B Simpson; N Taub; J D Thomas; J J Walker; K L M White; C P Wild; J E Cade
Journal:  Matern Child Health J       Date:  2013-05

3.  Differences in ovarian hormones in relation to parity and time since last birth.

Authors:  Emily S Barrett; Lauren E Parlett; Gayle C Windham; Shanna H Swan
Journal:  Fertil Steril       Date:  2014-03-28       Impact factor: 7.329

Review 4.  The international variation in breast cancer rates: an epidemiological assessment.

Authors:  B E Henderson; L Bernstein
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

Review 5.  A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the mother.

Authors:  Michael B Cook; Olof Akre; David Forman; M Patricia Madigan; Lorenzo Richiardi; Katherine A McGlynn
Journal:  Int J Epidemiol       Date:  2009-09-23       Impact factor: 7.196

6.  Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden.

Authors:  M Lambe; C C Hsieh; H W Chan; A Ekbom; D Trichopoulos; H O Adami
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Birth season and breast cancer risk in Japan.

Authors:  Y H Hu; T Kuroishi; Y Matsushita; C Nagata; H Shimizu
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Maternal age, parity, and pregnancy estrogens.

Authors:  K Panagiotopoulou; K Katsouyanni; E Petridou; Y Garas; A Tzonou; D Trichopoulos
Journal:  Cancer Causes Control       Date:  1990-09       Impact factor: 2.506

Review 9.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 10.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.